Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia
- 1 November 2012
- journal article
- Published by Elsevier BV in Clinical Biochemistry
- Vol. 45 (16-17), 1439-1443
- https://doi.org/10.1016/j.clinbiochem.2012.07.100
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- RAGE Mediates Accelerated Diabetic Vein Graft Atherosclerosis Induced by Combined Mechanical Stress and AGEs via Synergistic ERK ActivationPLOS ONE, 2012
- Enzymatic mechanisms regulating protein S-nitrosylation: implications in health and diseaseJournal of Molecular Medicine, 2012
- Neutrophil Gelatinase-Associated Lipocalin induces the expression of heme oxygenase-1 and superoxide dismutase 1, 2Cell Stress and Chaperones, 2010
- Involvement of Oxidative Stress in the Relapse of Acute Myeloid LeukemiaJournal of Biological Chemistry, 2010
- Protein S-nitrosylation in health and disease: a current perspectiveTrends in Molecular Medicine, 2009
- Plasma-Advanced Oxidation Protein Products Are Potent High-Density Lipoprotein Receptor Antagonists In VivoCirculation Research, 2009
- Oxidative Stress Promotes Transcriptional Up-regulation of Fyn in BCR-ABL1-expressing CellsJournal of Biological Chemistry, 2009
- Interaction of the RAGE Cytoplasmic Domain with Diaphanous-1 Is Required for Ligand-stimulated Cellular Migration through Activation of Rac1 and Cdc42Journal of Biological Chemistry, 2008
- Neutrophil Gelatinase-associated Lipocalin Acts as a Protective Factor against H2O2 ToxicityArchives of Medical Research, 2008
- Molecular mechanisms of transformation by the BCR-ABL oncogeneSeminars in Hematology, 2003